Nav: Home

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure

December 04, 2019

Nearly six million Americans have heart failure, a leading driver of health care costs in the United States. The "stiff heart" heart failure variant accounts for about half of all cases and the vast majority of such patients take beta-blocker medications despite unclear benefit from their regular use. A new publication in JAMA Network Open links use of beta-blockers to heart failure hospitalizations among those with this common "stiff heart" heart failure subtype.

Heart failure occurs when the heart cannot meet the body's demands. About half of patients have heart failure characterized by a normal squeeze but impaired relaxation of the heart muscle from a "stiff heart". This is also known as heart failure with preserved ejection fraction. The other half of cases are due to a "weak heart" with an abnormal squeeze, also known as heart failure with reduced ejection fraction. Beta-blockers--medications that lower the heart rate and blood pressure--are strongly recommended in national guidelines for treatment of "weak heart" heart failure because of their clear benefit.

"A big problem with 'stiff heart' heart failure is that we don't have effective medical therapies," says coauthor Timothy Plante, M.D., an assistant professor of medicine at the Larner College of Medicine at the University of Vermont. "So, instead, we use the same medications that work for 'weak heart' heart failure. Because beta-blockers save lives in 'weak heart' heart failure, we assume they are also effective in 'stiff heart' heart failure patients--this assumption may be wrong."

Plante, lead author Daniel Silverman, M.D., senior author Markus Meyer, M.D., and colleagues analyzed data from the National Institutes of Health-funded TOPCAT (Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist) study, a trial of the medication spironolactone in patients with "stiff heart" heart failure. About four out of five study participants were on beta-blockers.

The researchers found beta-blocker use to be a risk factor for hospitalizations for heart failure among these patients with "stiff heart" heart failure.

"Beta-blocker use was associated with a 74 percent higher risk of heart failure hospitalizations among participants with heart failure and a normal pump function," says Meyer, an associate professor of medicine at the University of Minnesota Medical School.

Despite their common use, the authors note that beta-blocker use in "stiff heart" heart failure has not been sufficiently studied. This publication extends their prior work, which found that halting beta-blockers markedly improves levels of the heart failure blood test known as BNP among patients with "stiff heart" heart failure.

"In 'stiff heart' heart failure, the heart is less able to relax and fill with blood. Beta-blockers appear to increase pressures inside the heart. This may lead to symptoms like worsening shortness of breath and retention of fluid," says Silverman, a cardiology fellow and clinical instructor in medicine at the University of Vermont Medical Center and Larner College of Medicine.

"Even people without heart failure will have more shortness of breath and less exercise capacity. This has been a known class side effect for decades," says Meyer. "It is important to understand that our findings are not proof that beta-blockers are harmful among patients with 'stiff heart' heart failure - it is just a concerning signal."

They believe their findings warrant a clinical trial to evaluate the safety and effects of beta-blockers in patients with "stiff heart" heart failure. "There are some big next steps, like reproducing this finding in other studies and testing if there is a benefit of stopping beta-blockers in patients with 'stiff heart' heart failure," says Silverman.
-end-


Larner College of Medicine at the University of Vermont

Related Heart Failure Articles:

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.
Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.
Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.
How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.
Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
NSAID impairs immune response in heart failure, worsens heart and kidney damage
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation.
Heart cell defect identified as possible cause of heart failure in pregnancy
A new Tel Aviv University study reveals that one of the possible primary causes of heart failure in pregnant women is a functional heart cell defect.
In heart failure, a stronger heart could spell worse symptoms
Patients with stronger-pumping hearts have as many physical and cognitive impairments as those with weaker hearts, suggesting the need for better treatment.
Patients with common heart failure more likely to have lethal heart rhythms
New Smidt Heart Institute Research shows that patients with Heart Failure with Preserved Ejection Fraction (HFpEF) are more likely to have lethal heart rhythms.
Why does diabetes cause heart failure?
A Loyola University Chicago Stritch School of Medicine study reveals how, on a cellular level, diabetes can cause heart failure.
More Heart Failure News and Heart Failure Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab